Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures. - Wikidata - awgldk - TriplyDB

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

http://www.wikidata.org/entity/Q27693845

about

Clinical Results of Complex Subtrochanteric Femoral Fractures with Long Cephalomedullary Hip Nail.

P2860

Q33781070-3144F0A0-51C2-40F5-A2B5-773E1D97BB1A

P2860

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

http://www.wikidata.org/entity/Q27693845

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@ast

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@en

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@nl

type

label

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@ast

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@en

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@nl

prefLabel

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@ast

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@en

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@nl

P1433

Q27693845-E2082253-2C3A-415C-8B1F-16E6A3E8B45F

P1476

Q27693845-CEF79BEE-973C-4494-9EEB-9C46EF444B8E

P2093

Q27693845-1EF2E9AB-1667-49B2-B8E3-1A7D01EAA1FD

Q27693845-35CA44F2-79CF-49B1-A873-175A608A467B

Q27693845-90B83EF2-2B43-4C1F-8196-4C24759588EB

Q27693845-97DD241C-48B6-4F71-92C2-11A18705A8BB

Q27693845-FBCEC32C-DDD8-4F7A-855D-688AAA2E7E50

P2860

Q27693845-0899E346-737A-49DB-97DB-6E126654D68B

Q27693845-09EF33CE-8715-4A65-998A-75DBE02BA9A2

Q27693845-0DE8E61B-15E5-4F04-84BA-47D372C4749E

Q27693845-1A9ABB4B-CB4B-441C-A820-769CCB4E5F2D

Q27693845-36BED81B-7C2B-4E8A-9BF1-440B2C3C6A40

Q27693845-3CB4719B-4258-4CAD-92D9-66A2B20D5845

Q27693845-481546AA-1B9F-41A6-B89F-D8CA9080F0D8

Q27693845-495614EA-E505-4DFD-856E-7129684FCCB8

Q27693845-514581E5-9BD1-4E6A-9380-BAAFAD3A2FC0

Q27693845-54004398-9337-44C5-A91F-4D8B19D85D0B

P304

Q27693845-2AB37256-51A0-4493-9206-416D06FCB3C6

P31

Q27693845-6238E14C-0798-4B4D-9FC2-A9EDA615BCF4

P356

Q27693845-D58C1959-112A-4A41-9F56-429B8896854B

P433

Q27693845-EE6C9977-DF8C-41B6-83D4-83E8071136DC

P478

Q27693845-515E1356-8D8A-48E1-975C-09901E08FAD3

P50

Q27693845-97C7689B-62CD-434E-9813-A556E677EEBA

P577

Q27693845-6B5790C8-3B0C-4778-AAC6-D2084DA70536

P5875

Q27693845-0D06E432-AF30-4624-ABB3-70E7DD272731

P698

Q27693845-D703D640-07AC-4E3E-8B1B-C8F833F4F1C3

P921

Q27693845-C783570B-054E-451D-B15A-AB1532D6B76A

P932

Q27693845-D1F29F5C-B7F5-49B9-8E90-44BA6EC24DEF

P356

P1433

P1476

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures.

@en

P2093

Byung-Woo Min

http://www.w3.org/2001/XMLSchema#string

Eun-Suck Son

http://www.w3.org/2001/XMLSchema#string

Ki-Cheor Bae

http://www.w3.org/2001/XMLSchema#string

Kwang-Soon Song

http://www.w3.org/2001/XMLSchema#string

Kyung-Jae Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record

Calcium supplement intake and risk of cardiovascular disease in women

Severely suppressed bone turnover: a potential complication of alendronate therapy.

Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

P304

9-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5371/HP.2015.27.1.9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276110251

http://www.w3.org/2001/XMLSchema#string

P698

27536596

http://www.w3.org/2001/XMLSchema#string

P921

P932

4972623

http://www.w3.org/2001/XMLSchema#string